In-Vitro Fertilization (IVF) Market is estimated to reach USD 26.2 Bn by 2027

The Global In-Vitro Fertilization (IVF) Market is estimated to reach USD 26.2 Bn by 2027, growing at a CAGR of 8.6% over the forecast period.

In recent years, the median age of first-time mother has increased due to late marriages, rising number of women who prioritize their professions over establishing a family, and improved contraceptive procedures are propelling factors for growth of the market. For instance, according to data published by the Australian Institute of Health and Welfare 2021, the average age of first-time mothers in Australia raised from 27.9 years to 31.9 years in 10 years (2009 to 2019). Due to this, the number of women increases who faces the problem to conceive naturally and thereby adopt in-vitro fertilization technique that drives the growth of in-vitro fertilization market.

The technological advancement of fertility techniques such as ICSI for treating infertility to increase fertility rate which is the propelling factor for growth of the market. The availability of genomic diagnostic facilities that allow for the prevention of genetic problem transmission during in vitro fertilization (IVF) is one of a major factors to fuel the growth of the global market. Rise in number of IVF treatments and availability of reimbursement for various IVF treatment are responsible for the acceleration of market.

Due to the outbreak of COVID-19, the Canadian Fertility and Andrology Society and the American Society of Reproductive Medicine in March 2020, restrict the in- person fertility treatments in the United States and Canada. Treatments are resuming in many developing countries, owing to the lack of prohibitions. For instance, Medicover Fertility, an IVF institution in India, in July 2020, announced that it would resume IVF procedures following the initial COVID-19 risk assessment. This resumption of IVF treatment is estimated to drive the market in developing countries over the forecast period.

Global In-Vitro Fertilization Market, by Region Outlook (Revenue, USD Billion, 2021-2027)

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America is estimated to dominate the global in-vitro fertilization market and followed by Europe over the forecast period owing to increasing prevalence of related disorders such as Poly-Cystic Ovarian Syndrome (PCOS). For instance, according to the single care online survey, in October 2020, in United States, among the total patients suffering from infertility, around 20% of patients adopt IVF. For instance, in April 2021, 19 states in North America passed the law for fertility insurance coverage that include IVF coverage, and 11 states had passed fertility preservation laws for iatrogenic (medically induced) infertility. As a result, it is estimated that the rate of treatment will increase, and demand for fertility treatment equipment will rise over the forecast period.

The Global In-Vitro Fertilization Market Segmentation:

Global In-Vitro Fertilization Market, by Products Outlook (Revenue, USD Billion, 2021-2027)

• Instruments
  • Sperm Analyzer Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Cryo-Systems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Other Instruments
• Reagents & Media
  • Cryopreservation Media
  • Ovum Processing Media
  • Embryo Culture Media
  • Sperm Processing Media
  • Chemicals
• Disposable/Accessories

Global In-Vitro Fertilization Market, by Procedure Type Outlook (Revenue, USD Billion, 2021-2027)

• Conventional In-Vitro Fertilization
• In-Vitro Fertilization with ICSI   

Global In-Vitro Fertilization Market, by Donor Type Outlook (Revenue, USD Billion, 2021-2027)

• Fresh Non-Donor
• Fresh Donor
• Frozen Non-Donor
• Frozen Donor

Global In-Vitro Fertilization Market, by End Users Outlook (Revenue, USD Billion, 2021-2027)

• Hospitals Labs
• Research Labs
• Fertility & Surgical Centers
• Cryo-Banks

Key Findings:

• Based on products, the instruments segment is expected to hold the largest share over the forecast period
• Based on procedure type, the in-vitro fertilization with ICSI segment is estimated to dominate over the forecast period due to tremendous success rate of this technique
• Based on donor type, the fresh non-donor segment projected to hold the largest share in in-vitro fertilization market over the forecast period
• Based on regions, the North America estimated to dominate the in-vitro fertilization market in the year 2027

Company Profiles and Competitive Intelligence

The key players operating in the in-vitro fertilization market are:

• Thermo Fisher Scientific, Inc.
• Esco Micro Pte. Ltd.
• The Cooper Companies Inc.
• Cook Group
• Merck KGaA
• Vitrolife
• Genea Limited
• IVFtech ApS
• FUJIFILM Irvine Scientific
• The Baker Company, Inc.
• Kitazato Corporation
• Rocket Medical plc.
• Hamilton Thorne Ltd.
• ZEISS Group
• FERTIPRO NV
• Gynotec B.V.
• Hamilton Thorne Ltd.
• Auxogyn, Inc.
• OvaScience, Inc.
• Boston IVF

Recent News:

• In February 2021, CooperSurgical (U.S.) established a co-operation with Virtus Health to expand its fertility technologies, making advanced therapy more accessible to infertile couples. This collaboration benefits the patients suffering from infertility, including those who need egg, sperm, or embryo donations, with a focus on digitalization, cryogenics, and reproductive genetics. This boosts PGTaiSM technology platform, and Virtus' applied medical expertise that contributing to the in-vitro fertilization market.
• In September 2021, Hamilton Thorne Ltd. (U.S.) got approval by FDA in the U.S. and Europe for the marketing of the GYNEMED GM501 media developed for in-vitro handling and washing handling procedures of human embryos and oocytes. This increases the product portfolio of the company.